P AEDIATRICS EMC IV 2015. A DULT VERSUS CHILD Anatomy upper and lower airway anatomy. less compliant ventricles in the myocardium. larger skin surface.

Slides:



Advertisements
Similar presentations
Body Composition Body Fatness.
Advertisements

Pediatric Fluids and Electrolytes
Pediatric Fluid & Electrolyte Management B. Paul Choate, M.D. Fort Carson MEDDAC.
Mosby items and derived items © 2005, 2002 by Mosby, Inc. CHAPTER 3 Life Span Considerations NDEG 26 A – Pharmacology 1 Eliza Rivera-Mitu, RN, MSN.
Selected Clinical Calculations
Dixie L. Thompson chapter 6 Body Composition. Important Terms Fat mass Fat-free mass Percent body fat Obesity Overweight Body fat distribution or fat.
Special Considerations in IV Therapy: The Pediatric and Geriatric Population Principles of IV Therapy BSN470.
VM 8314 Dr. Wilcke Drug Distribution. VM 8314 Dr. Wilcke  Vascular space =  Plasma/plasma water + (extracellular space)  Many RBC’s (intracellular.
Effect of Obesity on Kidney Transplantation Reference: Potluri K, Hou S. Obesity in kidney transplant recipients and candidates. Am J Kidney Dis. 2010;56:143–156.
CHAPTER 3 Life Span Considerations
Lifespan Considerations
Pharmacotherapy in the Elderly Judy Wong
Factors Affecting Distribution and Metabolism. Chemical Factors Lipophilicity Structure Ionization Chirality.
Energy needs.  Energy is require for all basic physiological functions  Breathing  Digestion  Excretion  Muscle function  mobility  heart  Brain.
One-compartment open model: Intravenous bolus administration
Pharmacokinetics Chapter 4.
Skinfold Measures.
.  3 INTRODUCTION  4 BODY FLUID COMPOSITION IN FETUSES AND NEWBORNS.
Yasar Kucukardali Professor, Internal Medicine Yeditepe University.
F LUID AND E LECTROLYTES B ALANCE IN C HILDREN. F LUID REPLACEMENT Replacing the fluid deficit, maintenance requirements and replacement of losses. Vital.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 10 Drug Therapy in Pediatric Patients.
Factors Affecting Drug Activity Chapter 11 Pages
Karel Allegaert, MD PhD UZ Leuven determinants of variability in disposition of exogenous compounds in neonates Clinical research supported by the Fund.
Objectives Describe the main physiological changes that occur with aging Identify factors affecting absorption and distribution with the geriatric client.
Dose Adjustment in Renal and Hepatic Disease
Chapter 5 Lifespan and Cultural Modifications Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc. 1.
Orientation to Pharmacology
Drug Therapy for Pediatric Clients Chapter 5. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Pediatric.
Pediatric Medication Administration Module D. Pediatric Classifications Age RangeClassifications < 38 weeks gestationPremature infant < 1 monthNeonate.
Animal Studies and Human Health Consequences Sorell L. Schwartz, Ph.D. Department of Pharmacology Georgetown University Medical Center.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 8 Individual Variation in Drug Responses.
U N I V E R S I T Y O F K E N T U C K Y - C O L L E G E O F P H A R M A C Y Pharmacokinetics & Drug Transport Philip E. Empey, Pharm.D., Ph.D., BCPS Assistant.
Illinois State University Body Composition: Children and Maturation Chapters 8 and 9.
Introduction More than 2 out of 3 adults and one third of children between 6 – 19 years of age are obese or overweight (1,2). Obese individuals accrued.
PHARMACOKINETICS CH. 4 Part 2. GETTING IN ABSORPTION Definition – the movement of a drug from the site of administration into the fluids of the body.
Basic Pharmacokinetics The time course of drug action Collected and Prepared By S.Bohlooli, PhD.
Fluid Therapy 24 April, 2009 review. Ⅰ Ⅰ fluid balance in child 1. The total amount of body fluids in children : The younger, The younger, the greater.
PHARMACOKINETIC MODELS
PEDIATRIC NURSING Caring For Children and Their Families MODULE 1.
Biopharmaceutics refers to the relationship of the:
1 Pharmacokinetics: Introduction Dr Mohammad Issa.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 3 Life Span Considerations.
Copyright ©2008 by Pearson Education, Inc. Upper Saddle River, New Jersey All rights reserved. Focus on Pharmacology, First Edition By Jahangir Moini.
PHT 415 BASIC PHARMACOKINETICS
1 Biopharmaceutics Dr Mohammad Issa Saleh. 2 Biopharmaceutics Biopharmaceutics is the science that examines this interrelationship of the physicochemical.
Drug Therapy in Pediatric Patients
Chapter 5 Staying Active and Managing Your Weight
PEDODONTICS 1-1 Dr. Abdullah Abumoamar.
By : Dr. Roshini Murugupillai
Drug therapy in pediatric
Chapter 9 PHARMACOKINETICS VARIABILITY
Pharmacokinetics: Pediatrics
Objectives Define body composition.
Updates on Policy #38 Addressing Subjects with Non-Average Heights and Weights 2017 SWOG Fall Meeting BOG Siu Fun Wong, PharmD Co-Chair, Pharmaceutical.
DRUGS USED IN PADEATRIC
Dehydration 7/14/05.
Dosing considerations in obese children
Pharmacokinetics: Pediatrics
Drug Therapy in Pediatric Patients
Factors affecting Drug Activity
Biopharmaceutics Dr Mohammad Issa Saleh.
Pharmacokinetics and Factors of Individual Variation
Dose measurement Lecturer: dr. Asmaa abdelaziz Mohamed
Clinical Pharmacokinetics
Therapeutic Drug Monitoring
Medication Administration for Pediatrics
Drug Therapy in Pediatric Patients
REFERENCE: APPLIED CLINICAL Slideshow by: lecturer HADEEL DELMAN
Presentation transcript:

P AEDIATRICS EMC IV 2015

A DULT VERSUS CHILD Anatomy upper and lower airway anatomy. less compliant ventricles in the myocardium. larger skin surface area. poorly formed blood brain barrier. These anatomical differences may then result in a difference in physiology. mike.shannonandmike.net

PHYSIOLOGY Physiologically, neonates have differences in various systems following separation from the placenta. Many of these functions resolve within a few days or weeks following birth, but others only years later (Porter, 2011). This becomes relevant for drug dosing!

PHARMACOKINETICS Absorption- GI changes Distribution- depends on 2 factors: body composition (water, fat and protein) and plasma protein binding. Metabolism - At normal doses some drugs may cause toxicity. Excretion - Immature kidneys, therefore elimination of drugs affected.

(Porter, 2011)

FLUID THERAPY Requirements for children are higher than those for adults for multiple reasons: “the higher metabolic rate of children requires a greater caloric expenditure, which translates into higher fluid requirements.” “children, especially infants, have a much higher body surface area to weight ratio, and this translates into relatively more water loss from skin compared with adults.” “children, especially infants, have higher respiratory rates, and this equates to higher insensible losses from the respiratory tract” (Meyers, 2009). The 3 types of fluid therapy are: Maintenance Deficit Replacement

DRUG-DOSING Drug dosing in children can be done using: Age-based formula- may be ineffective due to the varying growth patterns of children today and does not accurately reflect the pharmacokinetics at that specific developmental age. Weight-based formula- preferred method to calculate a drug dosage. Body surface area-based formula- complex and time- consuming. Allometric scaling- complicated and no longer used.

VOLUME OF DISTRIBUTION Total body weight (TBW) is the actual mass in kilograms weighed on a scale. The ideal body weight (IBW) is an estimation of weight based on sex, height and frame size. The lean body weight (LBW) is the TBW minus the fractional fat mass (measured using skinfold thickness or underwater weighing). The adjusted body weight (ABW) is calculated by adding a correction factor above the IBW to normalize the volume of distribution (Green & Duffull, 2004).

W EIGHT ESTIMATION METHODS Healthcare provider or parent guessing Age-based APLS Leffler’s Luscombe’s Best Guess etc. Length-based PAWPER Broselow Miscellaneous Mercy tape Haftel formula Bavdekar Formula Carroll Technique Mercy Tape- measurement-tapes

PAWPER Tape with body habitus Broselow Tape

REFERENCES Berlin, C., Pharmacokinetics in Children. [Online] Available at: n_children/pharmacokinetics_in_children.html [Accessed 6 June 2014]. n_children/pharmacokinetics_in_children.html Carasco, C., Fletcher, P. & Maconochie, I., Review of commonly used age based weight estimates for paediatric drug dosing in relation to the pharmacokinetic properties of resuscitation drugs. Archives of Disease in Childhood, 97(3), pp.A Fernandez, E. et al., Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and Adults. Pharmaceutics, 3(1), pp Green, B. & Duffull, S., What is the best size descriptor to use for pharmacokinetic studies in the obese? British Journal of Clinical Pharmacology, 58(2), pp Meyers, R.S, Paediatric fluid and electrolyte therapy. Journal of Paediatric Pharmacological Therapy. 14 (2), pp Porter, R., Merck Manual. 19th ed. New Jersey: Merck. Tayman, C., Rayyan, M. & Allegaert, K., Neonatal Pharmacology: Extensive Interindividual Variability Despite Limited Size. Journal of Pediatric Pharmacology and Therapeutics, 3(16), pp Wells, M., Weight prediction in children in the emergency department. Master of Science in Medicine in Emergency Medicine, University of Witswatersrand, Johannesburg. Wells, M., Goldstein, L. & Botha, M., Emergency Drug Dosing in Children: A Resuscitation Aid for Paediatric Emergencies. 1st ed. London: Elsevier.